Of note, ovarian cancer cell lines, when co-treated withbirinapant and TNFα exhibited >50% cell death at clinically achievabledoses of birinapant25 (Noonan et al.,manuscript in preparation). This evidence concerns the gene TNF and ovarian carcinoma.